Matches in SemOpenAlex for { <https://semopenalex.org/work/W4313578138> ?p ?o ?g. }
Showing items 1 to 88 of
88
with 100 items per page.
- W4313578138 endingPage "30" @default.
- W4313578138 startingPage "27" @default.
- W4313578138 abstract "The aim was to evaluate the impact of discontinuation of imatinib in children in chronic phase of chronic myeloid leukemia (CML) and assess treatment free remission (TFR). Patients and methods: We performed a retrospective study in children diagnosed with CML chronic phase up to 18 years of age, who were on imatinib for 5 years and had consistent BCR:ABL1 negative/undetectable transcripts through RT-PCR. Complete blood counts were monitored monthly and BCR:ABL1 transcripts by RT-PCR monitored 3 months. Results: Among the 14 patients who continued to remain PCR negative, we attempted discontinuing imatinib in eleven children as per the above-mentioned criteria. Eight (72%) continued to be in remission and did not require imatinib to be restarted. Among the remaining three patients, one child was noted to have increasing basophilia in the differential counts and was hence restarted on imatinib. Two other patients demonstrated recurrence of BCR:ABL1 transcript copy numbers six months after stopping TKI, following which imatinib was restarted. All three patients had documented major molecular response within three months of therapy. The median duration of TFR was 18 months in our cohort (range: 3 months–5 years). Among patients who continued to be off imatinib, TKI withdrawal symptoms were documented in 4 (36%) patients. Conclusions: Treatment free remission was achieved in 8/11 (72%) children after discontinuation of imatinib, and re-introduction of imatinib resulted in major molecular response in those with recurrence. Monitoring of BCR:ABL1 transcripts through RT PCR is essential." @default.
- W4313578138 created "2023-01-06" @default.
- W4313578138 creator A5013540107 @default.
- W4313578138 creator A5017204598 @default.
- W4313578138 creator A5029673673 @default.
- W4313578138 creator A5030029087 @default.
- W4313578138 creator A5031178892 @default.
- W4313578138 creator A5078978702 @default.
- W4313578138 creator A5079492300 @default.
- W4313578138 date "2023-03-01" @default.
- W4313578138 modified "2023-09-26" @default.
- W4313578138 title "Treatment free remission in pediatric chronic myeloid leukemia" @default.
- W4313578138 cites W2064367288 @default.
- W4313578138 cites W2117356576 @default.
- W4313578138 cites W2278657325 @default.
- W4313578138 cites W2744158693 @default.
- W4313578138 cites W2754183140 @default.
- W4313578138 cites W2802371729 @default.
- W4313578138 cites W2922314175 @default.
- W4313578138 cites W2981763967 @default.
- W4313578138 cites W2985463566 @default.
- W4313578138 cites W3007354017 @default.
- W4313578138 cites W3009751715 @default.
- W4313578138 cites W3022608130 @default.
- W4313578138 cites W3147240176 @default.
- W4313578138 cites W3194624016 @default.
- W4313578138 cites W3206705783 @default.
- W4313578138 cites W4223584148 @default.
- W4313578138 doi "https://doi.org/10.1016/j.phoj.2023.01.001" @default.
- W4313578138 hasPublicationYear "2023" @default.
- W4313578138 type Work @default.
- W4313578138 citedByCount "1" @default.
- W4313578138 countsByYear W43135781382023 @default.
- W4313578138 crossrefType "journal-article" @default.
- W4313578138 hasAuthorship W4313578138A5013540107 @default.
- W4313578138 hasAuthorship W4313578138A5017204598 @default.
- W4313578138 hasAuthorship W4313578138A5029673673 @default.
- W4313578138 hasAuthorship W4313578138A5030029087 @default.
- W4313578138 hasAuthorship W4313578138A5031178892 @default.
- W4313578138 hasAuthorship W4313578138A5078978702 @default.
- W4313578138 hasAuthorship W4313578138A5079492300 @default.
- W4313578138 hasBestOaLocation W43135781381 @default.
- W4313578138 hasConcept C126322002 @default.
- W4313578138 hasConcept C143998085 @default.
- W4313578138 hasConcept C170493617 @default.
- W4313578138 hasConcept C187212893 @default.
- W4313578138 hasConcept C2777583451 @default.
- W4313578138 hasConcept C2778715236 @default.
- W4313578138 hasConcept C2778729363 @default.
- W4313578138 hasConcept C2993416501 @default.
- W4313578138 hasConcept C3019892230 @default.
- W4313578138 hasConcept C43907098 @default.
- W4313578138 hasConcept C71924100 @default.
- W4313578138 hasConcept C72563966 @default.
- W4313578138 hasConcept C90924648 @default.
- W4313578138 hasConceptScore W4313578138C126322002 @default.
- W4313578138 hasConceptScore W4313578138C143998085 @default.
- W4313578138 hasConceptScore W4313578138C170493617 @default.
- W4313578138 hasConceptScore W4313578138C187212893 @default.
- W4313578138 hasConceptScore W4313578138C2777583451 @default.
- W4313578138 hasConceptScore W4313578138C2778715236 @default.
- W4313578138 hasConceptScore W4313578138C2778729363 @default.
- W4313578138 hasConceptScore W4313578138C2993416501 @default.
- W4313578138 hasConceptScore W4313578138C3019892230 @default.
- W4313578138 hasConceptScore W4313578138C43907098 @default.
- W4313578138 hasConceptScore W4313578138C71924100 @default.
- W4313578138 hasConceptScore W4313578138C72563966 @default.
- W4313578138 hasConceptScore W4313578138C90924648 @default.
- W4313578138 hasIssue "1" @default.
- W4313578138 hasLocation W43135781381 @default.
- W4313578138 hasOpenAccess W4313578138 @default.
- W4313578138 hasPrimaryLocation W43135781381 @default.
- W4313578138 hasRelatedWork W1975541563 @default.
- W4313578138 hasRelatedWork W1978637950 @default.
- W4313578138 hasRelatedWork W2037101530 @default.
- W4313578138 hasRelatedWork W2088660297 @default.
- W4313578138 hasRelatedWork W2172152327 @default.
- W4313578138 hasRelatedWork W2237792098 @default.
- W4313578138 hasRelatedWork W2415784939 @default.
- W4313578138 hasRelatedWork W3139178955 @default.
- W4313578138 hasRelatedWork W3197361064 @default.
- W4313578138 hasRelatedWork W4313578138 @default.
- W4313578138 hasVolume "8" @default.
- W4313578138 isParatext "false" @default.
- W4313578138 isRetracted "false" @default.
- W4313578138 workType "article" @default.